Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Lesions in Native Coronary Arteries”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Not applicableStudy completedNCT00792753
What this trial is testing

Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 360
Not applicableStudy completedNCT00314275
What this trial is testing

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System

Who this might be right for
Coronary Artery Disease
Medtronic Vascular 43
Post-approval studies (Phase 4)Ended earlyNCT00917163
What this trial is testing

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Who this might be right for
Coronary Artery Disease
Sahajanand Medical Technologies Limited 13
Testing effectiveness (Phase 2)Study completedNCT00233818
What this trial is testing

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 15
Not applicableLooking for participantsNCT06959524
What this trial is testing

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

Who this might be right for
Coronary Arterial Disease (CAD)de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation 1,616
Not applicableEnded earlyNCT04025788
What this trial is testing

BIOSOLVE-IV Magmaris Swiss Satellite Registry

Who this might be right for
Coronary Artery Disease
University Hospital, Geneva 10
Not applicableStudy completedNCT04282148
What this trial is testing

Abbott Next Generation Drug Eluting Stent 48mm Study

Who this might be right for
Coronary Artery Disease
Abbott Medical Devices 107
Not applicableStudy completedNCT01687075
What this trial is testing

CRE8 in All Comers Patients

Who this might be right for
Consecutive Subjects Who Are Suitable for a CoronaryAngioplasty of de Novo Lesion(s) in Native CoronaryArteries Should be Screened for Eligibility.+3 more
Tel-Aviv Sourasky Medical Center 215
Not applicableStudy completedNCT00726453
What this trial is testing

The Medtronic RESOLUTE US Clinical Trial

Who this might be right for
Coronary Artery Disease
Medtronic Vascular 1,516
Not applicableStudy completedNCT01425281
What this trial is testing

ABSORB II Randomized Controlled Trial

Who this might be right for
Coronary Artery Disease
Abbott Medical Devices 501
Not applicableStudy completedNCT02013349
What this trial is testing

DESolve Post-Approval Study

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 102
Large-scale testing (Phase 3)Study completedNCT00180453
What this trial is testing

SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

Who this might be right for
Coronary Artery DiseaseEverolimusVascular Disease+2 more
Abbott Medical Devices 60
Not applicableStudy completedNCT00927940
What this trial is testing

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent

Who this might be right for
Arterial Occlusive DiseasesMyocardial IschemiaCardiovascular Diseases+1 more
Medtronic Vascular 100
Large-scale testing (Phase 3)Ended earlyNCT00322543
What this trial is testing

Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)

Who this might be right for
Coronary Disease
Conor Medsystems 3
Testing effectiveness (Phase 2)UnknownNCT00744107
What this trial is testing

Cobra II Study: Use of the Cobra™ Cobalt Super Alloy Coronary Stent System in the Treatment of Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Medlogics Device Corporation 258
Post-approval studies (Phase 4)Study completedNCT00495898
What this trial is testing

Diabetic Patients With De Novo Native Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 200
Not applicableEnded earlyNCT00606333
What this trial is testing

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions

Who this might be right for
Coronary Atherosclerosis
Cordis US Corp. 394
Not applicableStudy completedNCT01150500
What this trial is testing

RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries

Who this might be right for
Arterial Occlusive DiseasesMyocardial IschemiaCardiovascular Diseases+1 more
Medtronic Vascular 65
Not applicableStudy completedNCT01485081
What this trial is testing

Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)

Who this might be right for
Coronary Disease
MINVASYS 52
Not applicableActive Not RecruitingNCT04157153
What this trial is testing

First in Men Study: BIOMAG-I

Who this might be right for
Coronary Artery Disease
Biotronik AG 116
Load More Results